Navigation Links
2006: A mixed blessing for Midwest life science companies

The Dow Jones Industrials had a fabulous year and outperformed the NASDAQ Composite index, which itself had a very solid year, by a large margin. The two key biotech indices, the NASDAQ and the Amex, trended differently, mostly because the different composition of each.

The......

Full article >>> the biggest impression on me is Whispers From A Spiritual Garden because it makes you feel that you are with Yusuf in the mosque with Islamic musical strains, voices, and rhythms, and yet it is also classic Cat Stevens.

Finally, the album is recorded in London, Los Angeles, Istanbul, and Johannesburg, and reflects several musical directions. After listening to this album more than 10 tim......

Full article >>> and board member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. WTN, LLC accept......

Full article >>> 4.39 680.91 +11% AMEX Pharmaceutical* 345.06 319.99 +11%

Source: Yahoo, 12/31/06

*Includes 15 pharma companies: Abbott, Amgen, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, King Pharmaceuticals, GlaxoSmithkline, Forest Labs, Eli Lilly, Merck, Pfizer, Schering Plough, Sanofi-Aventis, Teva Phar......

Full article >>> /tr> 11. Stryker (SYK) Michigan $55.11 $44.90 +23% $22.4 12. Archer Daniel Midland (ADM) Illinois $31.96 $24.75 +29% $21.0 13. Zimmer (ZMH) Indiana $78.38 $67.64 +16% $18.7 14. St. Jude Medical (STJ)
Full article >>> td> <22%> $.8


*Stock split on 7/31/06


**Acquired in a merger by a consortium of private equity companies (see below)


Stock Price Leaders - 2006

Company, % Growth

1. AllScripts, +99%

2. Monsanto, +34%

3. Archer Daniel Midland, +29%

4. Stericycle, +29......

Full article >>> f out for sale as the founders were looking for a way to cash out; instead of attracting the likes of another major orthopedic device company, a private equity consortium consisting of the Blackstone Group, Goldman Sachs Capital Partners, Abraxis Bioscience suffered, in spite of the successful launch of its new cancer drug Abraxane, as a result of the merger of the publicly-traded American Pharmaceutical Partners into the privately-held company for what many investors deemed to be outrageous terms that seemed to only benefit fo......

Full article >>> m does not ring any bells, try this name: Cat Stevens.

As we have heard a lot from Clapton over the last number of years, and virtually nothing for almost 30 years from Cat Stevens, I will focus my comments on the latter in this article and catch up on Clapton-Cale in a future article.

During my Midwestern college years in the early 1970s, the height of the anti-Vietnam W......

Full article >>> b>Comeback Cat

During 1968, Stevens was afflicted with tuberculosis and took off a few years from his music career to recover, re-emerging in 1970 with a new album, Mona Bone Jakon, and the popularly acclaimed album Tea for the Tillerman that same year. The next year also was a good year for Stevens as he released Teaser and Wildcat, which included two hits: Peace Train and Morning Ha......

Full article >>> out the life of the prophet Muhammad.

During the first years of the new century, post- 9/11, Islam/Stevens was in the news again when in 2004 he was refused entry into the U.S. and his flight to the U.S diverted, as his name, erroneously, showed up on a U.S. terrorist watch list. In September 2006, Stevens/Islam signed with Atlantic Records and......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/03/07


Related biology technology :

1. 2006: A great biotech financing year, unless you were going public!
2. DEMO 2006: A sea change is coming
3. Midwest small-cap life sciences turn in mixed third-quarter results
4. Human cloning plans get blessing from British government
5. Midwest life science stocks kept sizzling in Q2
6. Midwest life science stocks sizzle in a tepid first quarter
7. A Midwest passage to India, Part II
8. Midwest offers non-stop flight to North Carolina research park
9. A Midwest life-science odyssey comes full circle
10. Midwest hotter for healthcare investments
11. A Midwest small-cap, life-science surprise package
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... Bulk food ... bulk foods at various stages of the production process. Despite frequently inspecting loose ... bulk products post packaging such as sacks of dry powders. , Mettler-Toledo Product ...
(Date:2/8/2016)... 2016 --> ... "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces ... trachomatis (CT) test to be launched on the Company,s io® ... the CT test is now cleared for sale within the ... The launch of the io® CT test signals a new ...
(Date:2/5/2016)... Feb. 5, 2016 On Thursday, February 11, ... source for community, health and disaster services, and the ... integrate to enhance care coordination and service delivery for ... they need and to better connect service providers to ... San Diego has handled more ...
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases ... from Vigilant Solutions. Brian Wenberg explains, ... victim was walking out of a convenience store and witnessed an elderly male ... vehicle, striking his vehicle and leaving the scene.  In ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):